Last reviewed · How we verify
Lipidem 20%
At a glance
| Generic name | Lipidem 20% |
|---|---|
| Sponsor | B. Braun Melsungen AG |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- The HOME Study (HPN With OMEGA-3) (PHASE4)
- Comparison of Two Different Lipid Emulsions for Parenteral Nutrition in Preterm Infants (PHASE2)
- Effects Of Fish Oil Emulsion On Severe Acute Pancreatitis Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lipidem 20% CI brief — competitive landscape report
- Lipidem 20% updates RSS · CI watch RSS
- B. Braun Melsungen AG portfolio CI